Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Nov 8, 2016; 8(31): 1327-1335
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1327
Table 2 Overall age-adjusted survival in resected stage 1 and 2 hepatocellular cancer patients: Honolulu, United States, Tokyo, Japan and Shanghai, China
CenterHonoluluTokyoShanghai
No. patients146250177
No. deaths29176
Mean follow-up (yr)4.043.753.55
Median follow-up (yr)3.332.834.36
1-yr survivalHazard ratio110.280.63
95%CIReference0.15-0.510.32-1.21
P value< 0.00010.17
5-yr survivalHazard ratio10.70.74
95%CIReference0.50-0.980.51-1.09
P value0.040.13